Korro Bio

KORRO BIO INC

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Korro Bio Inc

Health Care

Press Releases

Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update

News

Korro to Present at the TD Cowen 45th Annual Health Care Conference

KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency

Earnings

Korro Reports Full Year 2024 Financial Results and Provides Business Updates

Management

Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

Korro to Participate in Upcoming Investor Conferences

Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110

Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates

Korro to Participate in Upcoming Investor and Scientific Conferences

KRRO

Altimmune

Amarin Corporation plc - American Depositary Shares

Amarin Corp

Annexon

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Aura Biosciences

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

DiaMedica Therapeutics Inc. - Common Stock

DiaMedica Therapeutics

Design Therapeutics

Editas Medicine

enGene Holdings

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Immuneering Corporation - Class A Common Stock

Immuneering

Invivyd

Kamada

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lyell Immunopharma

Neurogene

PureTech Health plc - American Depositary Shares

PureTech Health

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Vanda Pharmaceuticals Inc. - Common Stock

Comments

Korro Bio

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO